O14 THE CANNABINOID CB1 RECEPTOR INVERSE AGONIST, RIMONABANT, MODIFIES BODY WEIGHT AND ADIPONECTIN mRNA BY MODULATING FOOD INTAKE Article

Thornton-Jones, ZD, Vickers, SP, Kennett, GA et al. (2005). O14 THE CANNABINOID CB1 RECEPTOR INVERSE AGONIST, RIMONABANT, MODIFIES BODY WEIGHT AND ADIPONECTIN mRNA BY MODULATING FOOD INTAKE . Behavioural Pharmacology, 16(Supplement 1), s22-s23. 10.1097/00008877-200509001-00071

cited authors

  • Thornton-Jones, ZD; Vickers, SP; Kennett, GA; Benwell, KR; Revell, DF; Misra, A; Sellwood, DM; Clifton, PG

authors

publication date

  • September 1, 2005

published in

keywords

  • 2.1 Biological and endogenous factors
  • 32 Biomedical and Clinical Sciences
  • 3214 Pharmacology and Pharmaceutical Sciences
  • 52 Psychology
  • 5202 Biological Psychology
  • Cannabinoid Research
  • Cardiovascular
  • Endocannabinoid System Research
  • Neurosciences
  • Nutrition
  • Obesity
  • Oral and gastrointestinal
  • Therapeutic Cannabinoid Research

Digital Object Identifier (DOI)

publisher

  • Wolters Kluwer

start page

  • s22

end page

  • s23

volume

  • 16

issue

  • Supplement 1